Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06633133

Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision

Comparing the Safety and Efficacy of Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision for Rectal Cancer: a Multicentre, Prospective, Open-label, Blinded Endpoint, PROBE Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
620 (estimated)
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn to compare the safety and efficacy of virtual ileostomy versus diverting ileostomy in patients undergoing sphincter-saving surgery for rectal cancer. The main questions it aims to answer are: * Is the virtual ileostomy a safe and effective alternative to the ileostomy? * Is it scientifically reasonable to perform diverting ileostomy intraoperatively? Researchers will compare virtual ileostomy to diverting ileostomy to see if the virtual ileostomy works to reduce rates of stoma. Participants will: * Performing diverting ileostomy or virtual ileostomy undergoing sphincter-saving surgery for rectal cancer * Continuous follow-up of their complications after the first surgery

Detailed description

This study is a national multicenter, large-sample, randomized controlled study

Conditions

Interventions

TypeNameDescription
PROCEDUREVirtual ileostomyA pre-stage ileostomy, anchored under the abdominal wall by a vascular sling or rubber tape through the mesenteric window, is delivered to the outside of the abdomen, where the VI is pulled through the abdominal wall.

Timeline

Start date
2024-10-10
Primary completion
2026-12-01
Completion
2030-10-01
First posted
2024-10-09
Last updated
2024-10-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06633133. Inclusion in this directory is not an endorsement.